Trade Call: Eli Lilly

3 months ago

Parkev Tatevosian, CFA

"The next stock I rated as one of the best ones to buy is Eli Liy, which is trading at a market price of $8.96. And the intrinsic value per share I calculated is $1,317. Eli Liy is gaining investor attention because of its weight loss and diabetes treatment, with the oral pill version expected to come out early next year, which is likely to open a much larger market opportunity. Despite current negative sentiment driven by the administration's stance on healthcare, I see this as an opportunity given its strong drug pipeline and historical innovation."

Trade call for Eli Lilly based on a significant intrinsic undervaluation and robust pipeline in weight loss and diabetes treatments, seen as an opportunity amid regulatory headwinds.

Related Stocks